Why 2022 could be the most crucial year yet for gene editing

Hello, Welcome to Insider Healthcare. We’re healthcare editors Lydia Ramsey Pflanzer and Leah Rosenbaum. Today in healthcare news:If you’re new to this newsletter, sign up here. Comments, tips? Email me at lrosenbaum@insider.com or tweet @leah_rosenbaum. Let’s get to it…First off, a quick reminder that today is the last edition before the newsletter goes on hiatus. While we won’t be in your inboxes every weekday during the hiatus, we do still want to keep you informed with the latest healthcare news.Be sure to follow the healthcare team on Twitter at @HealthInsider, or email us at lramsey@insider.com and lrosenbaum@insider.com if you have a tip or thought about what’s going on in the world of healthcare.Insider will be in touch soon with some newsletter updates. For now: Marianne Ayala/Insider Why 2022 will be CRISPR’s most important year, according to more than 20 gene-editing experts Dive in>> Medical imaging service in a hospital in Savoie, France. A technician monitors a brain MRI scan session. BSIP/Universal Images Group via Getty Images How a new hope for treating Alzheimer’s turned into one of the worst drug launches in historyRead more>> CVS pharmacy Johnny Louis/Getty Images Check it out>>We’ll leave you with a few more great stories from this past month: – Lydia & Leah
https://www.businessinsider.com/insiders-top-healthcare-stories-for-december-21-2021-12